Opendata, web and dolomites
H2020 projects about "immunosuppressive"
The page lists 35 projects related to the topic "immunosuppressive".
| # | |||
|---|---|---|---|
| 1 | Paragone | PARAGONE: vaccines for animal parasites | 2015 |
| 2 | Rethyming | Rebuilding the human thymus to create a tolerising system for allogeneic tissue and organ transplantation | 2015 |
| 3 | NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages | 2015 |
| 4 | DRIVE | Diabetes Reversing Implants with enhanced Viability and long-term Efficacy | 2015 |
| 5 | TRANSBIO | A BIOmarker-based assay for prognosis and monitoring in renal TRANSplantation | 2015 |
| 6 | ImMoRiSt | Immune Monitoring for RIsk STratification in Solid Organ Transplant Recipients | 2016 |
| 7 | SAFEIMMUNOSUPPRESS | Development of immunosuppressive treatments with better safety | 2016 |
| 8 | Tissue-Tregs | Novel approaches to determining the function of tissue-specific regulatory T cells | 2016 |
| 9 | CHEMCHECK | CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy | 2016 |
| 10 | TRANSBIO | Cellular BIOtechnology for prognosis and monitoring in renal TRANSplantation | 2017 |
| 11 | PROGLUTASIS | Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis | 2017 |
| 12 | CriTiClean | Supercritical carbon dioxide for delipidation of soft tissue - Suppressing transplant rejection. | 2017 |
| 13 | MArylAND | At the host-bacteria interface: Modulation of the intestinal microbiota and its metabolic activity by Card9 signalling in health and Inflammatory Bowel Diseases | 2017 |
| 14 | CAR ART | Chimeric Antigen Receptor to generate Alloantigen-specific Regulatory T cells and promote allograft tolerance | 2017 |
| 15 | SynPlex | Tailored chemical complexity through evolution-inspired synthetic biology | 2017 |
| 16 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 17 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
| 18 | Tracer-T | Analysis of the effect of the tumour microenvironment on T cell functional phenotype | 2018 |
| 19 | DIRECT Therapies | Diabetes Immunoengineering: Redesigning Encapsulated Cell Transplant Therapies | 2018 |
| 20 | STIMUNO | Searching for novel strategies improving cancer immunotherapy | 2019 |
| 21 | MechanoIMM | Mechanical Immunoengineering for Enhanced T-cell Immunotherapy | 2018 |
| 22 | MitoGuide | Integration and adaptation of impaired mitochondrial fitness in orchestrating T cell dysfunction in the tumor microenvironment | 2019 |
| 23 | LIPOBITS | Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D) | 2018 |
| 24 | EpiTune | Epigenetic fine-tuning of T cells for improved adoptive cell therapy | 2019 |
| 25 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
| 26 | DECOMPACT | Development of Collagenase Polymeric nanocapsules as Therapeutics | 2019 |
| 27 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
| 28 | DADA2GT | Development of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiency | 2019 |
| 29 | MIMIC | Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 |
| 30 | KiT-FIG | Kidney Transplantation - Functional ImmunoGenomics | 2019 |
| 31 | ISACS | Improving Safety and comfort for kidney transplanted patients by enabling Accurate therapeutic drug monitoring through quantitative Capillary home Sampling | 2019 |
| 32 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 33 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
| 34 | Kidney-Treg | Characterisation and impact of kidney-resident Tregs in kidney physiology and pathologies | 2020 |
| 35 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |